Phosphoproteomic Response To MEK Inhibition

ABSTRACT: SILAC Heavy and Light cells were treated for 24 hours with each MEKi vs. Control in duplicate (Heavy/Light as well as Light/Heavy). For phosphoproteomic analysis, cells were treated for either 30 minutes or 24 hours with each MEKi vs. Control.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Skin Melanoma

SUBMITTER: Christopher Tape  

LAB HEAD: Chris Marshall

PROVIDER: PXD002621 | Pride | 2019-11-12

REPOSITORIES: Pride